Resistance studies with daptomycin

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 6, 2001, Pages 1799-1802

  Silverman, Jared A ^a   Oliver, Nicole ^a   Andrew, Ted ^a   Tongchuan, L I ^a  

^a CUBIST PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DAPTOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CHEMICAL MUTAGENESIS; CONTROLLED STUDY; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; MEMBRANE POTENTIAL; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; ANTI-BACTERIAL AGENTS; CELLS, CULTURED; DAPTOMYCIN; DRUG RESISTANCE, MICROBIAL; ENTEROCOCCUS; FEMALE; LETHAL DOSE 50; MEMBRANE POTENTIALS; MICE; MICROBIAL SENSITIVITY TESTS; MUTAGENESIS; PHENOTYPE; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0035021080     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.6.1799-1802.2001     Document Type: Article

References (29)

1. Alborn, W. E., Jr., N. E. Allen, and D. A. Preston. 1991. Daptomycin disrupts membrane potential in growing Staphylococcus aureus. Antimicrob. Agents Chemother. 35:2282-2287.
2. Allen, N. E., W. E. Alborn, Jr., and J. N. Hobbs, Jr. 1991. Inhibition of membrane potential-dependent amino acid transport by daptomycin. Antimicrob. Agents Chemother. 35:2639-2642.
3. Boaretti, M., and P. Canepari. 1995. Identification of daptomycin-binding proteins in the membrane of Enterococcus hirae. Antimicrob. Agents Chemother. 39:2068-2072.
4. Boaretti, M., P. Canepari, M. del Mar Lleò, and G. Satta. 1993. The activity of daptomycin on Enterococcus faecium protoplasts: indirect evidence supporting a novel mode of action on lipoteichoic acid synthesis. J. Antimicrob. Chemother. 31:227-235.
5. Canepari, P., M. Boaretti, M. del Mar Lleó, and G. Satta. 1990. Lipoteichoic acid as a new target for activity of antibiotics: mode of action of daptomycin (LY146032). Antimicrob. Agents Chemother. 34:1220-1226.
6. Chambers, H. F. 1997. Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Clin. Microbiol. Rev. 10:781-791.
7. Chatterjee, A. N. 1969. Use of bacteriophage-resistant mutants to study the nature of the bacteriophage receptor site of Staphylococcus aureus. J. Bacteriol. 98:519-527.
8. de Lencastre, H., A. M. Sà Figueiredo, C. Urban, J. Rahal, and A. Tomasz. 1991. Multiple mechanisms of methicillin resistance and improved methods for detection in clinical isolates of Staphylococcus aureus. Antimicrob. Agents Chemother. 35:632-639.
9. Eliopoulous, G. M., C. Thauvin, B. Gerson, and R. C. Moellering. 1985. In vitro activity and mechanism of action of A21978C1, a novel cyclic lipopeptide antibiotic. Antimicrob. Agents Chemother. 27:357-362.
10. Finney, D. J. 1971. Probit analysis, 3rd ed. Cambridge University Press, Cambridge, United Kingdom.
11. Flandrois, J. P., G. Carret, C. Pichat, and M. Peyret. 1988. Mise en évidence d'un effet inoculum sur l'estimation de la concentration minimale inhibitrice du LY 146032. Pathol. Biol. 36:377-380. (Summary in English.)
12. 2+ and albumin on these drugs. Antimicrob. Agents Chemother. 35:1710-1716.
13. Hartman, B. J., and A. Tomasz. 1986. Expression of methicillin resistance in heterogeneous strains of Staphylococcus aureus. Antimicrob. Agents Chemother. 29:85-92.
14. Howe, R. A., M. Wootton, T. R. Walsh, P. M. Bennett, and A. P. MacGowan. 1999. Expression and detection of hetero-vancomycin resistance in Staphylococcus aureus. J. Antimicrob. Chemother. 44:675-678.
15. Jolliffe, L. K., R. J. Doyle, and U. N. Streips. 1981. The energized membrane and cellular autolysis in Bacillus subtilis. Cell 25:753-763.
16. Kaatz, G. W., S. M. Seo, V. N. Reddy, E. M. Bailey, and M. J. Rybak. 1990. Daptomycin compared with teicoplanin and vancomycin for therapy of experimental Staphylococcus aureus endocarditis. Antimicrob. Agents Chemother. 34:2081-2085.
17. Kashket, E. R., A. G. Blanchard, and W. C. Metzger. 1980. Proton motive force during growth of Streptococcus lactis cells. J. Bacteriol. 143:128-134.
18. Liebowitz, L. D., J. Saunders, L. J. Chalkley, and H. J. Koornhof. 1988. In vitro selection of bacteria resistant to LY146032, a new cyclic lipopeptide. Antimicrob. Agents Chemother. 32:24-26.
19. Louie, A., A. L. Baltch, W. J. Ritz, R. P. Smith, and M. Asperilla. 1993. Comparison of in vitro inhibitory and bactericidal activities of daptomycin (LY 146032) and four reference antibiotics, singly and in combination, against gentamicin-susceptible and high-level-gentamicin-resistant enterococci. Chemotherapy 39:302-310.
20. Mates, S. M., L. Patel, H. R. Kaback, and M. H. Miller. 1983. Membrane potential in anaerobically growing Staphylococcus aureus and its relationship to gentamicin uptake. Antimicrob. Agents Chemother. 23:526-530.
21. Miller, J. H. 1972. Experiments in molecular genetics. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
22. Mouton, R. P., and S. L. T. M. Mulders. 1987. LY146032: activity and resistance development in vitro. J. Antimicrob. Chemother. 20:513-517.
23. National Committee for Clinical Laboratory Standards. 2000. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 5th ed. Document M7-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa.
24. Rottenberg, H. 1979. The measurement of membrane potential and ΔpH in cells, organelles, and vesicles. Methods Enzymol. 55:547-569.
25. Rybak, M. J, E. Hershberger, T. Moldovan, and R. G. Grucz. 2000. In vitro activities of daptomycin, vancomycin, linczolid, and quinupristin-dalfopristin against staphylococci and enterococci, including vancomycin-intermediate and -resistant strains. Antimicrob. Agents Chemother. 44:1062-1066.
26. Snydman, D. R., N. V. Jacobus, L. A. McDermott, J. R. Lonks, and J. M. Boyce. 2000. Comparative in vitro activities of daptomycin and vancomycin against resistant gram-positive pathogens. Antimicrob. Agents Chemother. 44:3447-3450.
27. Steinberg, D. A., M. A. Hurst, C. A. Fujii, A. H. C. Kung, J. F. Ho, F.-C. Cheng, D. J. Loury, and J. C. Fiddes. 1997. Protegrin-1: a broad-spectrum, rapidly microbicidal peptide with in vivo activity. Antimicrob. Agents Chemother. 41:1738-1742.
28. Tally, F. P., M. Zeckel, M. M. Wasilewski, C. Carini, C. L. Berman, G. L. Drusano, and F. B. Oleson, Jr. 1999. Daptomycin: a novel agent for Gram-positive infections. Exp. Opin. Investig. Drugs 8:1223-1238.
29. Wale, M. C. J., L. J. Wale, and D. Greenwood. 1988. Turbidimetric response of Staphylococcus aureus and Enterococcus faecalis to daptomycin. Eur. J. Clin. Microbiol. Infect. Dis. 7:809-812.